AR and neoplasm: Treatment of PCa tumours containing the amplified AR with AR antagonists such as Enzalutamide, Apalutamide and Darolutamide may be ineffective as, although the drugs are still specific to the AR, they may not be able to antagonise all AR proteins [78,79].